male cba mice (Charles River Laboratories)
86
Structured Review
Charles River Laboratories
male cba mice
Male Cba Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cba/42+design+experimental+thirty+two/pm42285199-47-0-3
Average 86 stars, based on 1 article reviews
Male Cba Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cba/42+design+experimental+thirty+two/pm42285199-47-0-3
Average 86 stars, based on 1 article reviews
male cba mice - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Crocin Bleaching Assay:Article Title: Cerebellar Kv2.1 downregulation, cytoarchitectural alterations, and persistent motor impairments following subchronic phencyclidine exposure. Article Snippet: .. Article Title: Ceramide metabolism in oxidative and glycolytic muscle: Significance for lipid-induced insulin resistance Article Snippet: .. Article Title: Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons. Article Snippet: .. For some experiments, BALB/c, C57BL/6, and Article Title: Ceramide metabolism in oxidative and glycolytic muscle: significance for lipid-induced insulin resistance. Article Snippet: .. Material and methods 2.1 Animal Model and Article Title: BDNF and IL-33 Dynamics in an Ultrasound Stress Model of Fibromyalgia-like Phenotypes. Article Snippet: .. The experiment was conducted using male CBA, Article Title: Noisy neuronal populations effectively encode sound localization in the dorsal inferior colliculus of awake mice Article Snippet: .. Experiments were performed on 7–16 week- old Article Title: An inducible transgenic mouse model for familial hypertension with hyperkalaemia (Gordon's syndrome or pseudohypoaldosteronism type II) Article Snippet: Mutations in the novel serine/threonine WNK [With No lysine (= K)] kinases WNK1 and WNK4 cause PHAII (pseudohypoaldosteronism type II or Gordon’s syndrome), a rare monogenic syndrome which causes hypertension and hyperkalaemia on a background of a normal glomerular filtration rate.. Current animal models for PHAII recapitulate some aspects of the disease phenotype, but give no clues to how rapidly the phenotype emerges or whether it is reversible.. To this end we have created an inducible PHAII transgenic animal model that expresses a human disease-causing WNK4 mutation, WNK4 Q565E, under the control of the Tet-On system. Animal Model:Article Title: Ceramide metabolism in oxidative and glycolytic muscle: significance for lipid-induced insulin resistance. Article Snippet: .. Material and methods 2.1 Animal Model and other:Article Title: Short-term caloric restriction partially reprograms immune and microbial networks during acute DSS-induced colitis. Article Snippet: 40 Methods 41 Animals and Experimental Design 42 Thirty-two Single Cell:Article Title: An inducible transgenic mouse model for familial hypertension with hyperkalaemia (Gordon's syndrome or pseudohypoaldosteronism type II) Article Snippet: Mutations in the novel serine/threonine WNK [With No lysine (= K)] kinases WNK1 and WNK4 cause PHAII (pseudohypoaldosteronism type II or Gordon’s syndrome), a rare monogenic syndrome which causes hypertension and hyperkalaemia on a background of a normal glomerular filtration rate.. Current animal models for PHAII recapitulate some aspects of the disease phenotype, but give no clues to how rapidly the phenotype emerges or whether it is reversible.. To this end we have created an inducible PHAII transgenic animal model that expresses a human disease-causing WNK4 mutation, WNK4 Q565E, under the control of the Tet-On system. In Vitro:Article Title: An inducible transgenic mouse model for familial hypertension with hyperkalaemia (Gordon's syndrome or pseudohypoaldosteronism type II) Article Snippet: Mutations in the novel serine/threonine WNK [With No lysine (= K)] kinases WNK1 and WNK4 cause PHAII (pseudohypoaldosteronism type II or Gordon’s syndrome), a rare monogenic syndrome which causes hypertension and hyperkalaemia on a background of a normal glomerular filtration rate.. Current animal models for PHAII recapitulate some aspects of the disease phenotype, but give no clues to how rapidly the phenotype emerges or whether it is reversible.. To this end we have created an inducible PHAII transgenic animal model that expresses a human disease-causing WNK4 mutation, WNK4 Q565E, under the control of the Tet-On system. |